ADAR1 Capital Management reports acquisition of $1,434.84 in InMed Pharmaceuticals common shares
INM•ADAR1 Capital Management purchased 1,087 InMed Pharmaceuticals common shares at $1.32 each, bringing indirect beneficial ownership to 956,580 shares.
1. Share acquisition
ADAR1 Capital Management purchased 1,087 InMed Pharmaceuticals common shares at $1.32 each. Its indirect beneficial ownership rose to 956,580 common shares. Daniel Schneeberger, ADAR1's manager, is also listed as a 10% owner.
